| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.38B | 100.90B | 93.48B | 85.46B | 81.25B | 76.57B |
| Gross Profit | 38.12B | 37.15B | 32.25B | 27.83B | 26.22B | 24.88B |
| EBITDA | 11.38B | 11.66B | 8.88B | 7.00B | 6.92B | 6.68B |
| Net Income | 7.88B | 7.65B | 5.66B | 4.42B | 4.12B | 3.83B |
Balance Sheet | ||||||
| Total Assets | 83.11B | 89.66B | 85.23B | 77.82B | 73.91B | 67.63B |
| Cash, Cash Equivalents and Short-Term Investments | 20.13B | 21.16B | 11.63B | 15.31B | 18.62B | 12.51B |
| Total Debt | 1.94B | 1.27B | 1.14B | 666.00M | 513.00M | 576.00M |
| Total Liabilities | 23.92B | 30.33B | 32.32B | 31.47B | 31.05B | 28.61B |
| Stockholders Equity | 59.01B | 59.12B | 52.74B | 46.18B | 42.69B | 38.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.37B | -685.00M | -1.62B | 7.25B | 3.17B |
| Operating Cash Flow | 0.00 | 12.04B | 907.00M | 516.00M | 7.86B | 4.12B |
| Investing Cash Flow | 0.00 | -826.00M | -2.69B | -2.32B | -760.00M | -1.03B |
| Financing Cash Flow | 0.00 | -1.71B | -2.49B | -1.60B | -1.20B | -1.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥165.82B | 10.41 | ― | 2.03% | 6.69% | 29.94% | |
76 Outperform | ¥221.75B | 14.34 | 8.53% | 2.45% | 5.14% | -10.92% | |
66 Neutral | ¥5.94T | 42.68 | 9.46% | 1.52% | 1.60% | 5.80% | |
66 Neutral | ¥129.65B | 10.42 | 12.89% | 3.40% | 2.98% | 41.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥5.85B | 4.98 | ― | 4.13% | 2.76% | -10.23% | |
52 Neutral | ¥478.20B | 16.11 | 1.44% | 4.80% | 0.68% | ― |